Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the earnings conference call in respect of Unaudited Standalone and Consolidated Financial Results for the Quarter and nine months ended 31st December, 2024 held today i.e. 21st January, 2025 at 03:30 p.m. (IST) is available on the Company's website at https://www.indoco.com/inv-fin-concall-transcripts.asp. The Earnings Conference Call concluded at 04.20 p.m. (IST) on 21st January, 2025.

pdf

Indoco Remedies Ltd.

21 Jan 2025

279.10

7.78%

Indoco Remedies Results Earnings Call for Q3FY25

Conference Call with Indoco Remedies Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.

Indoco Remedies Ltd.

28 Oct 2024

279.10

7.78%

Earnings Call

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30-09-2024

pdf

Indoco Remedies Ltd.

24 Oct 2024

279.10

7.78%

Earnings Call

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the earnings conference call in respect of Unaudited Standalone and Consolidated Financial Results for the Quarter and half year ended 30th September, 2024 held today i.e. 24th October, 2024 at 03:30 p.m. (IST) is available on the Company's website at https://www.indoco.com/inv-fin-concall-transcripts.asp. The Earnings Conference Call concluded at 04.30 p.m. (IST) on 24th October, 2024.

pdf

Indoco Remedies Ltd.

24 Oct 2024

279.10

7.78%

Investor Presentation

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find enclosed herewith Investor Presentation on Financial Results for the Quarter and Half Year ended 30th September, 2024

pdf

Indoco Remedies Ltd.

26 Jul 2024

279.10

7.78%

Earnings Call

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the quarter ended 30-06-2024

pdf

Indoco Remedies Ltd.

24 Jul 2024

279.10

7.78%

Earnings Call

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, the audio recording of the earnings conference call in respect of Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2024 held today i.e. 24th July, 2024 at 03:30 p.m. (IST) is available on the Company's website at https://www.indoco.com/inv-fin-concall-transcripts.asp. The Earnings Conference Call concluded at 04.25 p.m. (IST) on 24th July, 2024.

pdf